GH Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Mov Disord. 2010 Apr 15;25(5):534-41. doi: 10.1002/mds.22838.
Essential tremor (ET) is among the more prevalent neurological disorders, yet prevalence estimates have varied enormously, making it difficult to establish prevalence with precision. We: (1) reviewed the worldwide prevalence of ET in population-based epidemiological studies, (2) derived as precisely as possible an estimate of disease prevalence, and (3) examined trends and important differences across studies. We identified 28 population-based prevalence studies (19 countries). In a meta-analysis, pooled prevalence (all ages) = 0.9%, with statistically significant heterogeneity across studies (I(2) = 99%, P < 0.001). In additional descriptive analyses, crude prevalence (all ages) = 0.4%. Prevalence increased markedly with age, and especially with advanced age. In the meta-analysis, prevalence (age >or= 65 years) = 4.6%, and in additional descriptive analyses, median crude prevalence (age >or= 60-65) = 6.3%. In one study of those age >or= 95 years, crude prevalence = 21.7%. Several studies reported ethnic differences in prevalence, although more studies are needed. Greater than one-third of studies show a gender difference, with most demonstrating a higher prevalence among men. This possible gender preference is interesting given clinical, epidemiological, and pathological associations between ET and Parkinson's disease. Precise prevalence estimates such as those we provide are important because they form the numerical basis for planned public health initiatives, provide data on the background occurrence of disease for family studies, and offer clues about the existence of environmental or underlying biological factors of possible mechanistic importance.
特发性震颤(ET)是较为常见的神经障碍之一,但患病率估计差异极大,因此难以精确确定其患病率。我们:(1)综述了基于人群的流行病学研究中 ET 的全球患病率,(2)尽可能精确地推导出疾病的患病率估计值,(3)检查了研究之间的趋势和重要差异。我们确定了 28 项基于人群的患病率研究(来自 19 个国家)。在荟萃分析中,汇总患病率(所有年龄组)为 0.9%,研究之间存在显著的异质性(I²=99%,P<0.001)。在其他描述性分析中,粗患病率(所有年龄组)为 0.4%。患病率随年龄增长显著增加,尤其是高龄组。在荟萃分析中,患病率(年龄≥65 岁)为 4.6%,在其他描述性分析中,年龄≥60-65 岁的中位数粗患病率为 6.3%。在一项年龄≥95 岁人群的研究中,粗患病率为 21.7%。有几项研究报告了患病率的种族差异,但还需要更多的研究。超过三分之一的研究显示出性别差异,其中大多数研究表明男性患病率较高。鉴于 ET 与帕金森病之间存在临床、流行病学和病理学关联,这种可能的性别偏好很有趣。我们提供的这种精确患病率估计很重要,因为它们为计划中的公共卫生举措提供了数值基础,为家族研究提供了疾病背景发生率的数据,并为可能具有重要机制意义的环境或潜在生物学因素的存在提供了线索。